Utama › Leukemia Mieloid Fase Kronik › Oregon
Kajian klinikal Leukemia Mieloid Fase Kronik di Oregon
4 kajian untuk Leukemia Mieloid Fase Kronik sedang mencari peserta di lokasi di Oregon.
Bandar di Oregon
Teks kajian rasmi (Bahasa Inggeris)
Study of Olverembatinib (HQP1351) in Patients With CML-CP
- Ascentage Investigative Site #1139, Portland
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06423911A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
- Oregon Oncology Specialists Salem, Salem
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 100 · Semua jantina · Dikemas kini 20 Jul 2026 · NCT07091019A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
- Oregon Health & Science University-Knight Cardiovascular Institute, Portland
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Apr 2026 · NCT05304377A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
- Willamette Valley Cancer Institute and Research Center, Eugene
- Oregon Health & Science University, Portland
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Jan 2026 · NCT06163430Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.